 Matthew Stone
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2022 | 530 | 3.180 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 42 | 1.930 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 43 | 1.520 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 129 | 1.490 |
Why?
| | Aortic Diseases | 3 | 2022 | 119 | 1.450 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 8 | 1.400 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2022 | 382 | 1.370 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 229 | 1.260 |
Why?
| | Fontan Procedure | 4 | 2023 | 180 | 1.080 |
Why?
| | Heart Transplantation | 4 | 2023 | 754 | 1.070 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2021 | 121 | 0.980 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 534 | 0.910 |
Why?
| | Postoperative Complications | 7 | 2020 | 2654 | 0.850 |
Why?
| | Central Venous Catheters | 2 | 2022 | 51 | 0.820 |
Why?
| | Heart Defects, Congenital | 4 | 2023 | 842 | 0.810 |
Why?
| | Aortic Coarctation | 1 | 2023 | 83 | 0.790 |
Why?
| | Coronary Circulation | 2 | 2022 | 143 | 0.790 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 21 | 0.780 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.770 |
Why?
| | Atrioventricular Block | 1 | 2022 | 37 | 0.770 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 112 | 0.760 |
Why?
| | Heart Neoplasms | 1 | 2022 | 50 | 0.750 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 267 | 0.750 |
Why?
| | Hemodynamics | 3 | 2021 | 1113 | 0.730 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.700 |
Why?
| | Echocardiography | 1 | 2023 | 642 | 0.680 |
Why?
| | Coronary Vessels | 1 | 2022 | 248 | 0.680 |
Why?
| | Coronary Angiography | 1 | 2022 | 317 | 0.670 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 307 | 0.630 |
Why?
| | Child | 19 | 2023 | 21935 | 0.610 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 32 | 0.600 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 6 | 0.590 |
Why?
| | Vascular Stiffness | 2 | 2020 | 494 | 0.590 |
Why?
| | Tissue and Organ Procurement | 1 | 2022 | 321 | 0.590 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 71 | 0.580 |
Why?
| | Septal Occluder Device | 1 | 2018 | 30 | 0.570 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 2031 | 0.570 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.560 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 189 | 0.560 |
Why?
| | Infant | 9 | 2023 | 9465 | 0.550 |
Why?
| | Laparoscopy | 2 | 2012 | 466 | 0.530 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 530 | 0.530 |
Why?
| | Heart Ventricles | 5 | 2023 | 788 | 0.520 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 167 | 0.520 |
Why?
| | Respiration, Artificial | 1 | 2019 | 645 | 0.470 |
Why?
| | Aortic Valve | 3 | 2023 | 351 | 0.460 |
Why?
| | Humans | 43 | 2023 | 137585 | 0.430 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 259 | 0.410 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 91 | 0.400 |
Why?
| | Retrospective Studies | 11 | 2023 | 15657 | 0.390 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 4 | 0.380 |
Why?
| | Ethics, Medical | 1 | 2012 | 84 | 0.380 |
Why?
| | Coronary Sinus | 1 | 2012 | 7 | 0.380 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 97 | 0.370 |
Why?
| | Health Resources | 1 | 2013 | 120 | 0.370 |
Why?
| | Pericardium | 1 | 2012 | 55 | 0.370 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 30 | 0.360 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 65 | 0.360 |
Why?
| | Infant, Newborn | 6 | 2023 | 6079 | 0.360 |
Why?
| | Renal Insufficiency | 1 | 2013 | 162 | 0.350 |
Why?
| | Treatment Outcome | 11 | 2022 | 10811 | 0.350 |
Why?
| | Suture Techniques | 1 | 2011 | 122 | 0.340 |
Why?
| | Diagnostic Errors | 1 | 2012 | 170 | 0.340 |
Why?
| | Insurance, Health | 1 | 2013 | 283 | 0.340 |
Why?
| | Tobacco Products | 2 | 2022 | 138 | 0.340 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 180 | 0.340 |
Why?
| | Child, Preschool | 8 | 2022 | 11074 | 0.320 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 79 | 0.310 |
Why?
| | Male | 24 | 2023 | 67762 | 0.310 |
Why?
| | Hospital Mortality | 2 | 2013 | 911 | 0.300 |
Why?
| | Hypertension | 1 | 2017 | 1295 | 0.290 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 321 | 0.280 |
Why?
| | Aorta | 4 | 2020 | 417 | 0.280 |
Why?
| | Smoking Cessation | 2 | 2022 | 442 | 0.280 |
Why?
| | Incidence | 5 | 2022 | 2804 | 0.280 |
Why?
| | Female | 23 | 2023 | 73304 | 0.270 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 193 | 0.250 |
Why?
| | Heart | 2 | 2020 | 655 | 0.240 |
Why?
| | Product Labeling | 2 | 2022 | 10 | 0.230 |
Why?
| | Pulmonary Artery | 3 | 2020 | 1086 | 0.230 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 40 | 0.230 |
Why?
| | Adenocarcinoma | 1 | 2012 | 940 | 0.220 |
Why?
| | Time Factors | 6 | 2022 | 6828 | 0.220 |
Why?
| | Jugular Veins | 2 | 2022 | 41 | 0.210 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 38 | 0.200 |
Why?
| | Sternotomy | 1 | 2022 | 26 | 0.200 |
Why?
| | Calcinosis | 2 | 2023 | 235 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.180 |
Why?
| | Fetal Diseases | 1 | 2023 | 173 | 0.180 |
Why?
| | Trachea | 2 | 2021 | 237 | 0.180 |
Why?
| | Risk Factors | 6 | 2022 | 10388 | 0.170 |
Why?
| | Norwood Procedures | 1 | 2021 | 29 | 0.170 |
Why?
| | Waiting Lists | 1 | 2022 | 266 | 0.170 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 209 | 0.170 |
Why?
| | Adolescent | 6 | 2021 | 21513 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2021 | 101 | 0.160 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 449 | 0.160 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 103 | 0.160 |
Why?
| | Cannula | 1 | 2018 | 20 | 0.150 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 198 | 0.150 |
Why?
| | Young Adult | 4 | 2020 | 13209 | 0.150 |
Why?
| | Recurrence | 1 | 2021 | 1060 | 0.140 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 810 | 0.140 |
Why?
| | Smoking | 2 | 2022 | 1627 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 900 | 0.130 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 552 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2021 | 3556 | 0.120 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3284 | 0.110 |
Why?
| | Double-Blind Method | 1 | 2018 | 1993 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.110 |
Why?
| | Research Design | 1 | 2020 | 1139 | 0.110 |
Why?
| | Risk Assessment | 3 | 2019 | 3457 | 0.100 |
Why?
| | Rural Health | 1 | 2013 | 80 | 0.100 |
Why?
| | Hospital Charges | 1 | 2013 | 44 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 69 | 0.100 |
Why?
| | Catheterization | 1 | 2013 | 179 | 0.100 |
Why?
| | Risk Adjustment | 1 | 2013 | 78 | 0.100 |
Why?
| | Tricuspid Valve | 1 | 2012 | 30 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2013 | 130 | 0.090 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 60 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 88 | 0.090 |
Why?
| | Anxiety | 1 | 2019 | 1035 | 0.090 |
Why?
| | Cryosurgery | 1 | 2012 | 59 | 0.090 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2607 | 0.090 |
Why?
| | Perfusion | 1 | 2012 | 213 | 0.090 |
Why?
| | Sirolimus | 1 | 2013 | 276 | 0.090 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 220 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 303 | 0.090 |
Why?
| | Esophagectomy | 1 | 2012 | 131 | 0.080 |
Why?
| | Medicare | 2 | 2013 | 773 | 0.080 |
Why?
| | Linear Models | 1 | 2013 | 849 | 0.080 |
Why?
| | Logistic Models | 2 | 2013 | 2074 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 175 | 0.080 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 294 | 0.080 |
Why?
| | Age Factors | 1 | 2017 | 3295 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 412 | 0.080 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 228 | 0.080 |
Why?
| | Systole | 2 | 2020 | 189 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 822 | 0.080 |
Why?
| | Lung Transplantation | 1 | 2012 | 313 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 398 | 0.080 |
Why?
| | Cattle | 1 | 2012 | 984 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1509 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 151 | 0.080 |
Why?
| | Prospective Studies | 2 | 2018 | 7604 | 0.080 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 201 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2014 | 827 | 0.070 |
Why?
| | Medicaid | 1 | 2013 | 435 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1483 | 0.070 |
Why?
| | Cohort Studies | 3 | 2023 | 5742 | 0.070 |
Why?
| | Databases, Factual | 1 | 2013 | 1357 | 0.070 |
Why?
| | Length of Stay | 1 | 2013 | 1215 | 0.070 |
Why?
| | Stroke Volume | 2 | 2020 | 612 | 0.070 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 530 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2014 | 5131 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2023 | 4193 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4030 | 0.050 |
Why?
| | United States | 3 | 2021 | 14841 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 62 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 98 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 171 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 815 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 312 | 0.050 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 168 | 0.050 |
Why?
| | Aged | 6 | 2021 | 23961 | 0.050 |
Why?
| | Middle Aged | 7 | 2021 | 33479 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 336 | 0.050 |
Why?
| | Smokers | 1 | 2022 | 145 | 0.040 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 10 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2691 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 664 | 0.040 |
Why?
| | Tobacco Use | 1 | 2021 | 64 | 0.040 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 40 | 0.040 |
Why?
| | Adult | 5 | 2021 | 37929 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 41 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 40 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3566 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 188 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 195 | 0.040 |
Why?
| | Lung | 1 | 2012 | 4060 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 145 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2236 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 474 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2020 | 341 | 0.040 |
Why?
| | Signal Transduction | 2 | 2023 | 5079 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1226 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 413 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 1002 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1710 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 266 | 0.030 |
Why?
| | Ventricular Function, Right | 1 | 2020 | 285 | 0.030 |
Why?
| | Animals | 3 | 2013 | 36940 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 922 | 0.030 |
Why?
| | RNA | 1 | 2021 | 921 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2844 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 81 | 0.020 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 86 | 0.020 |
Why?
| | Warm Ischemia | 1 | 2012 | 12 | 0.020 |
Why?
| | Citrates | 1 | 2012 | 44 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 52 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 84 | 0.020 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 45 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 121 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 30 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4295 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4149 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 416 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 573 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 126 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 268 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 179 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 233 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 600 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 372 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1272 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 327 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2012 | 279 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 591 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 139 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1972 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1325 | 0.020 |
Why?
| | Risk | 1 | 2012 | 912 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 513 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6763 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 425 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 179 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 339 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 967 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 956 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 362 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 1070 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 467 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1242 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1266 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5757 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7635 | 0.010 |
Why?
| | Mice | 1 | 2013 | 17787 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|